We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 10,000 results
  1. The RNA helicases DDX19A/B modulate selinexor sensitivity by regulating MCL1 mRNA nuclear export in leukemia cells

    Selinexor, a first-in-class exportin1 (XPO1) inhibitor, is an attractive anti-tumor agent because of its unique mechanisms of action; however, its...

    Tatsuya Terasaki, Yuichiro Semba, ... Takahiro Maeda in Leukemia
    Article 11 July 2024
  2. Anti-TIM3 chimeric antigen receptor-natural killer cells preferentially target primitive acute myeloid leukemia cells with minimal fratricide and exhaustion

    Acute myeloid leukemia (AML) is an aggressive and genetically heterogeneous disease with poor clinical outcomes. Refractory AML is common, and...

    Phatchanat Klaihmon, Parinya Samart, ... Sudjit Luanpitpong in Experimental Hematology & Oncology
    Article Open access 11 July 2024
  3. Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial

    Limited data is available on the health-related quality of life (HRQoL) and symptoms of patients with chronic myeloid leukemia (CML) who are in...

    Fabio Efficace, Francois-Xavier Mahon, ... Susanne Saussele in Leukemia
    Article 10 July 2024
  4. Causal inference of the effect of blood proteome on the risk of head and neck cancer: two-sample Mendelian randomization

    Early diagnosis of head and neck cancer can improve therapeutic outcomes but remains a challenge. The blood proteome can comprise a key source of...

    Zhen Wang, Jianhao Wu in Discover Oncology
    Article Open access 10 July 2024
  5. Regorafenib plus FOLFIRINOX as first-line treatment for patients with RAS-mutant metastatic colorectal cancer (FOLFIRINOX-R trial): a dose-escalation study

    Purpose

    The combination of bevacizumab and FOLFIRINOX is used in patients with RAS-mutant metastatic colorectal cancer (RASm-mCRC). Regorafenib, an...

    Antoine Adenis, François Ghiringhelli, ... Marc Ychou in Cancer Chemotherapy and Pharmacology
    Article Open access 10 July 2024
  6. Fueling CARs: metabolic strategies to enhance CAR T-cell therapy

    CAR T cells are widely applied for relapsed hematological cancer patients. With six approved cell therapies, for Multiple Myeloma and other B-cell...

    Arne Van der Vreken, Karin Vanderkerken, ... Eline Menu in Experimental Hematology & Oncology
    Article Open access 10 July 2024
  7. Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis

    Introduction

    The aim of the study was to determine the impact of positive surgical margins (PSM) after PN on very long-term recurrence in a...

    Maud Hulin, Victor Audigé, ... Zine‐Eddine Khene in International Journal of Clinical Oncology
    Article 09 July 2024
  8. Study of sex-biased differences in genomic profiles in East Asian hepatocellular carcinoma

    Hepatocellular carcinoma (HCC) is characterized by a notable sex disparity in incidence and tumor aggressiveness. Revealing differences in genetic...

    Chung-Yu Huang, Kien-Thiam Tan, ... Ka-Po Tse in Discover Oncology
    Article Open access 09 July 2024
  9. Hemolytic versus malproductive anemia in large granular lymphocytic leukemia

    Olisaemeka Ogbue, Tariq Kewan, ... Jaroslaw P. Maciejewski in Leukemia
    Article Open access 09 July 2024
  10. ZBTB7A regulates LncRNA HOTAIR-mediated ELAVL1/SOX17 axis to inhibit malignancy and angiogenesis in endometrial carcinoma

    Background

    Endometrial cancer (EC) is the sixth most frequent cancer in women worldwide and has higher fatality rates. The pathophysiology of EC is...

    **ao-Hui Zhang, Shu-Wei Wu, ... Yunxia Cao in Journal of Cancer Research and Clinical Oncology
    Article Open access 09 July 2024
  11. Develo** a deep learning model for predicting ovarian cancer in Ovarian-Adnexal Reporting and Data System Ultrasound (O-RADS US) Category 4 lesions: A multicenter study

    Purpose

    To develop a deep learning (DL) model for differentiating between benign and malignant ovarian tumors of Ovarian-Adnexal Reporting and Data...

    Wenting **e, Wenjie Lin, ... Guorong Lyu in Journal of Cancer Research and Clinical Oncology
    Article Open access 09 July 2024
  12. Investigation of prognostic values of immune infiltration and LGMN expression in the microenvironment of osteosarcoma

    Background

    Osteosarcoma (OS), the most common primary malignant bone tumor, predominantly affects children and young adults and is characterized by...

    Hualiang Xu, Dawei Xu, ... **aofei Zheng in Discover Oncology
    Article Open access 09 July 2024
  13. Baseline and early 18F-FDG PET/CT evaluations as predictors of progression-free survival in metastatic breast cancer patients treated with targeted anti-CDK therapy

    Background

    Exploring the value of baseline and early 18 F-FDG PET/CT evaluations in prediction PFS in ER+/HER2- metastatic breast cancer patients...

    Charline Lasnon, Adeline Morel, ... George Emile in Cancer Imaging
    Article Open access 09 July 2024
  14. Quality of life in women with breast cancer undergoing neoadjuvant chemotherapy: comparison between PICC and PICC-port

    Background

    Peripherally inserted central catheters (PICCs) and new type of arm-port, the PICC-port, are currently used for neoadjuvant chemotherapy...

    Fulvio Pinelli, Francesco Barbani, ... Gianluca Villa in Breast Cancer
    Article Open access 09 July 2024
  15. Association of body composition indicators with colorectal cancer: a hospital-based case-control study

    Purpose

    Colorectal cancer (CRC) is a common malignancy that affects adults worldwide, causing a high disease burden. Few studies have examined the...

    Qiu** Chen, Kai Li, ... Fengrong Ou in Journal of Cancer Research and Clinical Oncology
    Article Open access 09 July 2024
  16. Analysis of tumor abnormal protein expression and epidermal growth factor receptor mutation status in non-small cell lung cancer

    Background

    The level of tumor abnormal protein (TAP) level has a significant impact on tumor growth, recurrence, and metastasis. Previous studies have...

    Yuanjun Cheng, Bin Chen, ... Jie Yao in Discover Oncology
    Article Open access 09 July 2024
  17. Novel associations between MTDH gene polymorphisms and invasive ductal breast cancer: a case–control study

    Objective

    To reveal the contributing effects of MTDH gene SNPs in the risk of invasive ductal breast cancer (IDC).

    Patients and methods ...
    Yan Huang, Dan Dai, ... **anzhong Qi in Discover Oncology
    Article Open access 09 July 2024
Did you find what you were looking for? Share feedback.